Lung cancer is the primary cause of cancer-related mortality, claiming approximately 1.79 million lives globally in 2020, with an estimated 2.21 million new cases diagnosed within the same period. Among these, Non-Small Cell Lung Cancer (NSCLC) is the predominant subtype, characterized by a notably bleak prognosis and low overall survival rate of approximately 25% over five years across all disease stages. However, survival outcomes vary considerably based on the stage at diagnosis and the therapeutic interventions administered. Recent advancements in artificial intelligence (AI) have revolutionized the landscape of lung cancer prognosis. AI-driven methodologies, including machine learning and deep learning algorithms, have shown promise in enhancing survival prediction accuracy by efficiently analyzing complex multi-omics data and integrating diverse clinical variables. By leveraging AI techniques, clinicians can harness comprehensive prognostic insights to tailor personalized treatment strategies, ultimately improving patient outcomes in NSCLC. Overviewing AI-driven data processing can significantly help bolster the understanding and provide better directions for using such systems.
For most if not all cancers, prognosis is of significant importance, and extensive modeling research has been conducted. With the genetic nature of cancer, in the past two decades, multiple types of molecular data (such as gene expressions and DNA mutations) have been explored. More recently, histopathological imaging data, which is routinely collected in biopsy, has been shown as informative for modeling prognosis. In this study, using the TCGA LUAD and LUSC data as a showcase, we examine and compare modeling lung cancer overall survival using gene expressions versus histopathological imaging…
Perelman School of Medicine, University of Pennsylvania（宾夕法尼亚大学佩雷尔曼医学院）
Purpose: To utilize high-resolution quantitative CT (QCT) imaging features for prediction of diagnosis and prognosis in fibrosing interstitial lung diseases (ILD). Approach: 40 ILD patients (20 usual interstitial pneumonia (UIP), 20 non-UIP pattern ILD) were classified by expert consensus of 2 radiologists and followed for 7 years. Clinical variables were recorded. Following segmentation of the lung field, a total of 26 texture features were extracted using a lattice-based approach (TM model). The TM model was compared with previously histogram-based model (HM) for their abilities to classify …
School of Information Technology（信息技术学院）；University of Cincinnati（辛辛那提大学）
Lung cancer is the leading cause of death among different types of cancers. Every year, the lives lost due to lung cancer exceed those lost to pancreatic, breast, and prostate cancer combined. The survival rate for lung cancer patients is very low compared to other cancer patients due to late diagnostics. Thus, early lung cancer diagnostics is crucial for patients to receive early treatments, increasing the survival rate or even becoming cancer-free. This paper proposed a deep-learning model for early lung cancer prediction and diagnosis from Computed Tomography (CT) scans. The proposed mode a…
Eurecat, Centre Tecnològic de Catalunya（加泰罗尼亚技术中心 Eurecat）；Universitat Pompeu Fabra（庞培法布拉大学）；ICREA
The early identification of malignant pulmonary nodules is critical for better lung cancer prognosis and less invasive chemo or radio therapies. Nodule malignancy assessment done by radiologists is extremely useful for planning a preventive intervention but is, unfortunately, a complex, time-consuming and error-prone task. This explains the lack of large datasets containing radiologists malignancy characterization of nodules. In this article, we propose to assess nodule malignancy through 3D convolutional neural networks and to integrate it in an automated end-to-end existing pipeline of lung …
James A. Haley VA Hospital（詹姆斯·A·黑利退伍军人事务医院）；University of South Florida, Morsani College of Medicine（南佛罗里达大学莫萨尼医学院）
Lung cancer continues to be a major healthcare challenge with high morbidity and mortality rates among both men and women worldwide. The majority of lung cancer cases are of non-small cell lung cancer type. With the advent of targeted cancer therapy, it is imperative not only to properly diagnose but also sub-classify non-small cell lung cancer. In our study, we evaluated the utility of using Apple Create ML module to detect and sub-classify non-small cell carcinomas based on histopathological images. After module optimization, the program detected 100% of non-small cell lung cancer images and…
James A. Haley Veterans’ Hospital（詹姆斯·A·黑利退伍军人医院）；University of South Florida（南佛罗里达大学）；Moffitt Cancer Center（莫菲特癌症中心）
The field of Machine Learning, a subset of Artificial Intelligence, has led to remarkable advancements in many areas, including medicine. Machine Learning algorithms require large datasets to train computer models successfully. Although there are medical image datasets available, more image datasets are needed from a variety of medical entities, especially cancer pathology. Even more scarce are ML-ready image datasets. To address this need, we created an image dataset (LC25000) with 25,000 color images in 5 classes. Each class contains 5,000 images of the following histologic entities: colon a…
A Multimodal Foundation Model to Enhance Generalizability and Data Efficiency for Pan-cancer Prognosis Prediction
Department of Computer Science and Engineering（计算机科学与工程系）；Hong Kong University of Science and Technology（香港科学与技术大学）；Department of Pathology（病理学系）；School of Medicine（医学院）；Zhejiang University（浙江大学）；Nanfang Hospital and School of Basic Medical Sciences（南方医科大学基础医学系）；Southern Medical University（南方医学院）；Guangdong Provincial Key Laboratory of Molecular Tumor Pathology（广东省分子肿瘤病理重点实验室）；Jinfeng Laboratory（金凤实验室）；Department of Radiology（放射科）；Division of Life Science（生命科学系）；HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute（香港科技大学深圳-香港协同创新研究院）；State Key Laboratory of Nervous System Disorders（神经系统疾病国家重点实验室）
Motivation: Lung cancer is one of the leading causes for cancer-related death, with a five-year survival rate of 18%. It is a priority for us to understand the underlying mechanisms that affect the implementation and effectiveness of lung cancer therapeutics. In this study, we combine the power of Bioinformatics and Systems Biology to comprehensively uncover functional and signaling pathways of drug treatment using bioinformatics inference and multiscale modeling of both scRNA-seq data and proteomics data. The innovative and cross-disciplinary approach can be further applied to other computati…
Clínica Santa María（圣玛丽亚诊所）；Universidad de los Andes（洛斯安第斯大学）
Lung cancer is the leading cause of cancer death in the world. Accurate determination of the EGFR (epidermal growth factor receptor) mutation status is highly relevant for the proper treatment of this patients. Purpose: The aim of this study was to predict the mutational status of the EGFR in non-small cell lung cancer patients using radiomics features extracted from PET-CT images. Methods: Retrospective study that involve 34 patients with lung cancer confirmed by histology and EGFR status mutation assessment. A total of 2.205 radiomics features were extracted from manual segmentation of the P…
MicroRNAs play an indispensable role in numerous biological processes ranging from organismic development to tumor progression.In oncology,these microRNAs constitute a fundamental regulation role in the pathology of cancer that provides the basis for probing into the influences on clinical features through transcriptome data. Previous work focused on machine learning (ML) for searching biomarkers in different cancer databases, but the functions of these biomarkers are fully not clear. Taking lung cancer as a prototype case of study. Through integrating clinical information into the transcripts…
Lung cancer is currently the leading cause of cancer deaths. Among various subtypes, the number of patients diagnosed with stage I non-small cell lung cancer (NSCLC), particularly adenocarcinoma, has been increasing. It is estimated that 30 - 40\% of stage I patients will relapse, and 10 - 30\% will die due to recurrence, clearly suggesting the presence of a subgroup that could be benefited by additional therapy. We hypothesize that current attempts to identify stage I NSCLC subgroup failed due to covariate effects, such as the age at diagnosis and differentiation, which may be masking the res…
Nowadays, the screening methods for the early detection of lung cancer struggle with several limitations such as many false positive results and low sensitivity. The detection of specific biomarkers is of high interest to complement these conventional screening methods. The objective of this study is to prove the power of 1H-NMR in metabolomics for the detection of smoking behavior, which is the leading risk factor for lung cancer, and as such gain more insights in the metabolic alterations that are caused by smoking. In this research, 1H-NMR spectra of human blood plasma samples were divided …
Memorial Sloan Kettering Cancer Center（纪念斯隆凯特琳癌症中心）；Icahn School of Medicine at Mount Sinai（西奈山伊坎医学院）；Chalmers University of Technology（查尔姆斯理工大学）
Lung cancer is the leading cause of cancer death worldwide, with lung adenocarcinoma being the most prevalent form of lung cancer. EGFR positive lung adenocarcinomas have been shown to have high response rates to TKI therapy, underlying the essential nature of molecular testing for lung cancers. Despite current guidelines consider testing necessary, a large portion of patients are not routinely profiled, resulting in millions of people not receiving the optimal treatment for their lung cancer. Sequencing is the gold standard for molecular testing of EGFR mutations, but it can take several week…
If Electronic Health Records contain a large amount of information about the patients condition and response to treatment, which can potentially revolutionize the clinical practice, such information is seldom considered due to the complexity of its extraction and analysis. We here report on a first integration of an NLP framework for the analysis of clinical records of lung cancer patients making use of a telephone assistance service of a major Spanish hospital. We specifically show how some relevant data, about patient demographics and health condition, can be extracted; and how some relevant…
Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichment
Accenture Labs（埃森哲实验室）；Hospital Universitario Puerta de Hierro Majadahonda（马哈拉达翁达普埃尔塔德希罗大学医院）；University of Galway（戈尔韦大学）；Insight Centre for Data Analytics（洞察数据分析中心）；Hospital General de Valencia（瓦伦西亚综合医院）；Hospital Universitario de Jaén（哈恩大学医院）；Masaryk University（马萨里克大学）；Masaryk Memorial Cancer Institute（马萨里克纪念癌症研究所）；Hospital General Universitario de Alicante（阿利坎特综合大学医院）；University College London（伦敦大学学院）；Complejo Hospitalario Universitario A Coruña（拉科鲁尼亚大学医院综合体）；Hospital Universitario de Salamanca（萨拉曼卡大学医院）
Background: Stratifying cancer patients according to risk of relapse can personalize their care. In this work, we provide an answer to the following research question: How to utilize machine learning to estimate probability of relapse in early-stage non-small-cell lung cancer patients? Methods: For predicting relapse in 1,387 early-stage (I-II), non-small-cell lung cancer (NSCLC) patients from the Spanish Lung Cancer Group data (65.7 average age, 24.8% females, 75.2% males) we train tabular and graph machine learning models. We generate automatic explanations for the predictions of such models…
